ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 155.00
+26.00 (20.16%)
Jun 25, 2026, 2:03 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 11.47 billion as of June 25, 2026. Its market cap has increased by 395.50% in one year.
Market Cap
11.47B
Enterprise Value
10.50B
Revenue
38.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
155.00
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 990.62M to 11.47B, an increase of 1,057.47%. That is a compound annual growth rate of 64.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 9.19B | 127.38% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.97M | -5.21% |
| Jul 27, 2021 | 990.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ever Supreme Bio Technology | 14.40B |
| EirGenix | 14.10B |
| Tanvex BioPharma | 11.28B |
| Polaris Group | 11.26B |
| Locus Cell | 10.20B |
| AP Biosciences | 8.56B |
| PharmaEngine | 8.28B |
| Gongwin Biopharm Holdings | 8.08B |